相关实验视频
Updated: May 29, 2025

07:33
A Mouse Model of Intestinal Partial Obstruction
Published on: March 5, 2018
21.0K
治疗免疫媒介慢性肠道伪阻塞的新方法
Andreu Vilaseca1,2, Paula Arranz3, Arnau Llaurado2,3
1Neurology Department and Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Hospital Universitari de Vall d'Hebron, Barcelona, Spain.
Neurology(R) neuroimmunology & neuroinflammation
|February 5, 2025
概括
利图西马布和维多利祖马布在治疗自身免疫性慢性肠道伪阻塞 (CIPO) 方面表现有前途,该疾病不耐初始治疗. 这些生物制剂为CIPO患者提供了潜在的治疗选择,这些患者对标准免疫疗法没有反应.
科学领域:
- 胃肠病学 胃肠病学
- 免疫学 免疫学 免疫学
- 神经学 神经学
背景情况:
- 自免疫性慢性肠道伪阻塞 (CIPO) 缺乏已确定的最佳免疫抑制治疗方法.
- 对于对一线免疫疗法无反应的CIPO管理的数据有限.
研究的目的:
- 评估vedolizumab和rituximab在自身免疫性CIPO中的疗效.
- 探索耐火性CIPO案件的治疗选择.
主要方法:
- 4名患有自身免疫性CIPO的患者的病例系列,在失败的类固醇/IVIG后接受了vedolizumab或rituximab治疗.
- 系统性文献审查CIPO用这些生物制剂治疗的患者.
主要成果:
- 维多利祖马布在2/3的患者中有效,其中有孤立的CIPO没有神经元抗体.
- 维多利祖马布在一个患有抗Hu相关CIPO和dysautonomia的儿童中失败了.
- 利图西马布在一个与Hu相关的CIPO病例中显示出完整的反应;文献审查发现4个先前的利图西马布病例,其中2个反应.
结论:
- 利图西马布和维多利祖马布在对第一线治疗耐药的自身免疫性CIPO治疗中显示出潜在的疗效.
- 进一步的研究是有必要的,以确定在CIPO管理中这些代理物的最佳使用.
相关概念视频
Inflammatory Bowel Disease V: Surgical Management
103
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
103
Inflammatory Bowel Disease IV: Pharmacological Management
100
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
100
Drugs for Treatment of Constipation-Predominant IBS
130
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
130
Drugs for Treatment of Diarrhea-Predominant IBS
142
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
142
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
306
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
306
Chronic Pancreatitis II: Collaborative Care
60
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
60

